immunology Flashcards
type 4 delayed hypersensitivity reaction moa
doesn’t involve antibodies or complement; occurs 1-2 days after exposure as antigen is taken up by dendritic cells, displayed on MHCII, and stimulate Th1 to release interferon-gamma and attract MO
reactive arthritis triad, age group, and lab finding
urethritis, arthritis, and conjunctivitis; young men; HLA-B27
hep B markers of DNA replication
HBeAg, HBV DNA
hep B chronic infection lab findings
high HBeAg, low anti-HBeAg
eosinophil 2 functions
- defense against parasites: IgE detects parasites, binds and attracts eosinophil via IgE FcR, euosinophil releases major basic protein to kill parasite; 2. regulate type 1 hypersensitivity rxn (mediated by mast/basophils): by releasing histaminase, which helps reduce severity of atopic reaction
EBV nydus of infection
pharyngeal mucosa and tonsillar crypts, then blood
EBV binds to what receptor on what cell?
CD-21 (C3d complement receptor) on mature B-cells
EBV histological giveaway
CD8+ cells that clinically expand to destroy the virus-infected cells; appear much larger with lots of cytoplasm, eccentrically placed nucleus, and cell membrane that conforms to nearby cell bodies
monocotyes and macrophages: signals identity and serves as LPS receptor
CD14
type 1 hypersensitivity: moa
initial exposure: develop a wheal and undergo class-switching to IgE specific to antigen; re-exposure will result in cross-linking on the surface of basophils and mast cells, degranulation, and release of histamine, proteases, leukotrienes, prostaglandins, and heparin
TNF-alpha produced by what cells, does what, and is elevated in what diseases?
mast cells and macrophages; activation of inflammatory cells (CD4, PMN, fibroblasts, endothelial cells) and apoptosis of tumor cells; increased in inflammatory conditions like RA, psoriatic arthritis
Anti-TNF-alpha IG
infliximab, eternacept
toxic shock syndrome moa
superantigen that activates large numbers of helper T-cells (release IL-2) and MO (release IL-1 and TNF); cause capillary leakage, circulatory collapse, hypotension/shock, fever, and skin findings
TB: mycobacteria survival strategy
hide in MO, able to escape killing and replicate w/i phagollysozomes
TB: macrophage response
- present antigen to naive Th cells, 2. secrete IL-12 to induce Th1 differentiation (to produce interferon gamma to help MO), and 3. produce TNF-alpha to recruit additional MO to wall bacteria in
TB: histological hallmark
epithelioid MO
hep C genetic variation: 2 moa
hypervariable region for envelope glycoprotein; no proofreading 3’-5’ exonuclease activity on virion-encoded RNA polymerase
chronic granulomatous dz: moa, pw, dx
inactivation of NADPH oxidase leads to decreased oxidative burst and impaired phagocytic intracellular killing; pw recurrent infection with coag + bacteria, lungs, skin, LN, liver involved, w/ diffuse granulomatous formation; dx by measuring PMN superoxide products (DHR flow cytometry or nitroblue tetrazolium test)
Dihydrorhodamine flow cytrometry test
measures conversion of DHR to rhodamine (fluorescent green); decreased NADPH activity, decreased fluorescence
Nitroblue tetrazolium test
NADPH oxidaises yellow NBT to dark blue; if yellow, then dz positive
What disease presents similarly to chronic granulomatous disease?
myeloperoxidase deficiency (normal DHR/NBT test)
Chediak-higashi syndrome: moa, pw
AR defect in phagosome-lysosome fusino in PMN, leading to abnormal giant lysosomal inclusions visible on light microscopy; pw recurrent pyogenic infectino by strap, strep, albinism, neurological defects (nystagmus, neuropathy)
NK cell (10 percent of all lymphocytes): function, moa
destroy cells w decreased/absent MHCI (virus, tumor); release perforins that punch holes in membranes and granzymes that induce target cell apoptosis
NK cells surface markers
CD16, CD56
NK cells activated by
interferon gamma and IL-12
Th1 cell-mediated adaptive immunity: moa
targets intracellular pathogens, secrets IL-2, interferon- gamma to activates MO and cytotoxic T cells ; also mediates delayed-type hypersensitivity
Th2 cells humoral adaptive immunity: moa
secretes IL-4, IL-13 to promote B-cell IgE production, secretes IL-5 to promote eosinophil activity/IgA synthesis
Hypothesis for asthma
Increased Th2/Th1 activity; type 1 hypersensitivity, increased IgE
IL-1 secreted by who and stimulates what
Secreted by MO to stimulate helper T cells, fever
Acute hemolytic transfusion reaction moa
type 2 reaction (antibody-mediated) in which anti-ABO IgM antibodies binds with corresponding antigens on donor RBC, release C5b-C9 (MAC) and C3a-C5a (vasodilation, shock); pw fever, chills, hypotension, chest/back pain, hemoglobinuria, DIC, renal failure;
thymus and t-cell maturation
- pro t-cells arrive as “double-negative” without CD4, 8 antigens; 2. rearrangement of beta chain of TCR, production of CD4 and CD8 antigens (“double positive”); 3. @ thymic cortex, positive selection picks out T-cells that can bind with MHC cells on thymic epithelial cells (“positive selection”); 4. @ thymic medulla, deletion of t cells that react strongly to self-MHC antigens; 5. loss of CD4 or CD8 antigen
GVH disease
m/c after BMT, liver transplant, transfusion of non-irradiated blood; host is severely immunodeficient and donor T cells w/i transplanted tissue recognize host MHC as foreign and attack; pw liver dmg (jaundice, elevated transaminases, alk phos, bili), GI symptoms, and skin desquamation
sarcoidosis moa
accumulation of activated MO, formation of noncaseating granulomas (that produce ACE and active vita D), dysregulated cell-mediated immune response (increased CD4/CD8, Il-2, IFN-gamma)
ataxia-telengiectasia moa, pw
ATM mutation responsible for DNA break repair; pw ataxia, telengiectasia, immunodeficiency (both cell and humoral) leads to IgA deficiency and respiratory infections
HIV binds to what receptors
CD4 and CCR5
langerhans cell
derived from myeloid line, dendritic cell in skin/mucosa, professional APC, constitutive expression of MHCII and B7 molecules; histo: “racquet-shaped” cell with intracytoplasmic granules (birbeck)